Skip to main content

Immune Response BioPharma, Inc.

Home
Drug Discovery
Press Releases
Investor Relations
Royalties
Stock Information
Executive Team
Scientific Board
Clinical Trials
REMUNE Vaccine
REMUNE Rx Co-pay Card
REMUNE FULL PRESCRIBING
REMUNEX Vaccine
Remune Pediatric
RemuneVax Vaccine
NeuroVax Vaccine
NeurOral
RAVAX Vaccine
RAVAX II Vaccine
Zorcell Vaccine
DermaVax
Immunereszumab
Sepsicillin
Rare Diseases
Alliances
Vaccines Direct
Partnering
Bio Defense
Immune Response Hospital
Orchestra Therapeutics
Research Donations
About Us
Corporate Filings
Corporate ByLaws
Transfer Agent
Employment
Events
Webcast
Contact Us
Email Alerts
Member Login
Site Map
 Immune Response BioPharma, Inc. TM            

Remune Pediatric HIV Vaccine  (C) copyright 2017-2018

Remune Pediatric HIV Vaccine BLA Filing  March 31st 2017

Remune FDA Orphan Designated 


Remune Pediatric 808 Study Principal Investigator: Lauren Wood M.D. NIH NCI

Phase I-II Study 808 N=10 Subjects 









Study 808B Phase I-II N=22 Additional Subjects Total N=32 

 Immune Response BioPharma, Inc. TM  www.Immuneresponse.net   All Rights Reserved (C) 2017-2018